7-benzyl-5-(piperazin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-amine

ID: ALA1098433

PubChem CID: 46887825

Max Phase: Preclinical

Molecular Formula: C20H25N7

Molecular Weight: 363.47

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Nc1n[nH]c2nc(N3CCNCC3)c3c(c12)CCN(Cc1ccccc1)C3

Standard InChI:  InChI=1S/C20H25N7/c21-18-17-15-6-9-26(12-14-4-2-1-3-5-14)13-16(15)20(23-19(17)25-24-18)27-10-7-22-8-11-27/h1-5,22H,6-13H2,(H3,21,23,24,25)

Standard InChI Key:  DBTYVHTVNGKJBW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
    3.8422  -18.1425    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5599  -17.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2747  -18.1444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9883  -16.9005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9886  -17.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7790  -17.9881    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2674  -17.3156    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7786  -16.6435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0333  -15.8588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5611  -16.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2721  -16.4892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2683  -15.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5551  -15.2606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8441  -15.6755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8463  -16.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1282  -15.2656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1252  -14.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8378  -14.0291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8352  -13.2049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1187  -12.7942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4034  -13.2137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4095  -14.0365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1287  -17.7242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4132  -18.1317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4060  -18.9591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1206  -19.3773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8424  -18.9681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  6  7  1  0
 14 16  1  0
  7  8  2  0
 16 17  1  0
  8  4  1  0
 17 18  2  0
  4  5  1  0
 18 19  1  0
  8  9  1  0
 19 20  2  0
  2  1  1  0
 20 21  1  0
 10 11  1  0
 21 22  2  0
 22 17  1  0
  1 23  1  0
 10  2  2  0
  2  3  1  0
  3  5  2  0
  4 11  2  0
  1 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1098433

   7-benzyl-5-(piperazin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-amine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 363.47

Molecular Weight (Monoisotopic): 363.2171

AlogP: 1.51

#Rotatable Bonds: 3

Polar Surface Area: 86.10

Molecular Species: BASE

HBA: 6

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.76

CX LogP: 2.08

CX LogD: 0.69

Aromatic Rings: 3

Heavy Atoms: 27

QED Weighted: 0.65

Np Likeness Score: -1.09

References

1. Guo C, Guzzo PR, Hadden M, Sargent BJ, Yet L, Kan Y, Palyha O, Kelly TM, Guan X, Rosko K, Gagen K, Metzger JM, Dragovic J, Lyons K, Lin LS, Nargund RP..  (2010)  Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists.,  20  (9): [PMID:20371178] [10.1016/j.bmcl.2010.03.065]

Source

Source(1):

• Scientific Literature